clinical trial · NCT02949362
Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
Shire·phase3·completed·n = 29
Short Bowel SyndromeTeduglutideSOC
brief summary
The purpose of this study is to evaluate the safety and efficacy of teduglutide treatment of children with short bowel syndrome (SBS) who completed the TED-C13-003 study over a long-term period. It will evaluate how these children fared after the TED-C13-003 study ended. This study will also offer teduglutide treatment to eligible subjects, regardless of treatment received in TED-C13-003.
started
Dec 9, 2016
primary completion
Jul 14, 2020
completion
Jul 14, 2020
last updated
Mar 19, 2025
official title
A Retrospective and Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed TED-C13-003
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol